Literature DB >> 21741035

B cell infiltration is associated with the increased IL-17 and IL-22 expression in the lungs of patients with tuberculosis.

Mingxia Zhang1, Zheng Wang, Michael W Graner, Lin Yang, Mingfeng Liao, Qianting Yang, Jizhou Gou, Yuzhen Zhu, Chi Wu, Haiying Liu, Boping Zhou, Xinchun Chen.   

Abstract

Although it has been recognized that ectopic follicle-like B cell aggregate formation is common in the lungs of patients with tuberculosis, the role of infiltrated B cells in human tuberculosis remains to be elucidated. In the present study, we showed that ectopic B cell aggregate formation was associated with containment of Mycobacterium tuberculosis. The area ratio of ectopic B cell aggregates was correlated with localized IL-17 mRNA expression and peripheral TGF-β and IL-6 mRNA expression. Depletion of B cells from pleural fluid mononuclear cells resulted in significantly diminished M. tuberculosis antigen-specific IL-17 and IL-22 production, but not in IFN-γ secretion. Therefore, ectopic lung B cell formation is important for containment of M. tuberculosis, and up-regulation of IL-17 and IL-22 responses may be an important mechanism underlying the protective role B cells in human tuberculosis.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21741035     DOI: 10.1016/j.cellimm.2011.05.009

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  15 in total

1.  Activated B cells in the granulomas of nonhuman primates infected with Mycobacterium tuberculosis.

Authors:  Jia Yao Phuah; Joshua T Mattila; Philana L Lin; JoAnne L Flynn
Journal:  Am J Pathol       Date:  2012-06-19       Impact factor: 4.307

Review 2.  Biological and pathological activities of interleukin-22.

Authors:  Mirna Perusina Lanfranca; Yanwei Lin; Jingyuan Fang; Weiping Zou; Timothy Frankel
Journal:  J Mol Med (Berl)       Date:  2016-02-29       Impact factor: 4.599

Review 3.  Latent tuberculosis infection: myths, models, and molecular mechanisms.

Authors:  Noton K Dutta; Petros C Karakousis
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

4.  Immune Cell Networks Uncover Candidate Biomarkers of Melanoma Immunotherapy Response.

Authors:  Duong H T Vo; Gerard McGleave; Ian M Overton
Journal:  J Pers Med       Date:  2022-06-11

5.  Prevalence of open-angle glaucoma in southwestern China: the Yongchuan Glaucoma study.

Authors:  Hua Li; Yong-Ye Zhang; Shi-Chun Liu; Xiang-Ge He; Chong-Jin Li; Chun-Hua Li; Ge Li; Ji Xu; Yu-Fei Wu; Sheng-Fang Song
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-02-06

6.  Alterations in the peripheral blood B cell subpopulations of multidrug-resistant tuberculosis patients.

Authors:  Mónica T Abreu; Helena Carvalheiro; Tiago Rodrigues-Sousa; António Domingos; António Segorbe-Luis; Paulo Rodrigues-Santos; M Margarida Souto-Carneiro
Journal:  Clin Exp Med       Date:  2013-09-26       Impact factor: 3.984

7.  Inhibition of CD73 improves B cell-mediated anti-tumor immunity in a mouse model of melanoma.

Authors:  Giovanni Forte; Rosalinda Sorrentino; Antonella Montinaro; Antonio Luciano; Ian M Adcock; Piera Maiolino; Claudio Arra; Carla Cicala; Aldo Pinto; Silvana Morello
Journal:  J Immunol       Date:  2012-07-23       Impact factor: 5.422

Review 8.  Subversion of the B-cell compartment during parasitic, bacterial, and viral infections.

Authors:  Gwenoline Borhis; Yolande Richard
Journal:  BMC Immunol       Date:  2015-03-26       Impact factor: 3.615

9.  Emerging trends in the formation and function of tuberculosis granulomas.

Authors:  Geanncarlo Lugo-Villarino; D Hudrisier; A Benard; Olivier Neyrolles
Journal:  Front Immunol       Date:  2013-01-07       Impact factor: 7.561

10.  Combination of gene expression patterns in whole blood discriminate between tuberculosis infection states.

Authors:  Adane Mihret; Andre G Loxton; Yonas Bekele; Stefan H E Kaufmann; Martin Kidd; Mariëlle C Haks; Tom H M Ottenhoff; Abraham Aseffa; Rawleigh Howe; Gerhard Walzl
Journal:  BMC Infect Dis       Date:  2014-05-13       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.